Cargando…
Metabolic Response of Triple-Negative Breast Cancer to Folate Restriction
Background: Triple-negative breast cancers (TNBCs), accounting for approximately 15% of breast cancers, lack targeted therapy. A hallmark of cancer is metabolic reprogramming, with one-carbon metabolism essential to many processes altered in tumor cells, including nucleotide biosynthesis and antioxi...
Autores principales: | Coleman, Michael F., O’Flanagan, Ciara H., Pfeil, Alexander J., Chen, Xuewen, Pearce, Jane B., Sumner, Susan, Krupenko, Sergey A., Hursting, Stephen D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152779/ https://www.ncbi.nlm.nih.gov/pubmed/34068120 http://dx.doi.org/10.3390/nu13051637 |
Ejemplares similares
-
Metabolic reprogramming underlies metastatic potential in an obesity-responsive murine model of metastatic triple negative breast cancer
por: O’Flanagan, Ciara H., et al.
Publicado: (2017) -
Obesity and Cancer Metabolism: A Perspective on Interacting Tumor–Intrinsic and Extrinsic Factors
por: Doerstling, Steven S., et al.
Publicado: (2017) -
When less may be more: calorie restriction and response to cancer therapy
por: O’Flanagan, Ciara H., et al.
Publicado: (2017) -
Sex-Specific Metabolic Effects of Dietary Folate Withdrawal in Wild-Type and Aldh1l1 Knockout Mice
por: Sharma, Jaspreet, et al.
Publicado: (2022) -
Aldh1l2 knockout mouse metabolomics links the loss of the mitochondrial folate enzyme to deregulation of a lipid metabolism observed in rare human disorder
por: Krupenko, Natalia I., et al.
Publicado: (2020)